Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2349)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (22)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4744)
  2. Department of Medicine (4742)
  3. Center for Pancreatic Cancer Research (2312)
  4. Surgery (1065)
  5. Survivorship Research (1013)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (219)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (147)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (320)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4744)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MOUNTAINEER-02: Phase II/III study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma (GEC): Trial in progress
    Meeting Abstract

    Catenacci, D. V.; Strickler, J. H.; Shitara, K.; Nakamura, Y.; Janjigian, Y. Y.; Barzi, A.; Bekaii-Saab, T.; Lenz, H. J.; Chung, H. C.; Tabernero, J.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Lanreotide autogel/depot (LAN) in patients with advanced bronchopulmonary (BP) neuroendocrine tumors (NETs): Results from the phase III SPINET study
    Meeting Abstract

    Baudin, E.; Horsch, D.; Singh, S.; Caplin, M. E.; Ferone, D.; Wolin, E. M.; Capdevila, J.; Buikhuisen, W. A.; Raderer, M.; Dansin, E.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • FORTITUDE phase I study of NG-350A, a novel tumour-selective adenoviral vector expressing an anti-CD40 agonist antibody: Monotherapy dose escalation results
    Meeting Abstract

    Naing, A.; Rosen, L.; Camidge, R. D.; Khalil, D.; Davies, J.; Miles, D.; Patel, M.; Cockle, P.; Champion, B.; Krige, D.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Clinical outcomes and immune responses in a phase I/II study of personalized, neoantigen-directed immunotherapy in patients with advanced MSS-CRC, GEA and NSCLC
    Meeting Abstract

    Catenacci, D. V.; Liao, C. Y.; Maron, S.; Solomon, B. J.; Mahipal, A.; Johnson, M. L.; Carbone, D.; Henick, B. S.; Johnson, B.; Roychowdhury, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Pembrolizumab (pembro) for previously treated, microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): Final analysis of KEYNOTE-164
    Meeting Abstract

    Le, D. T.; Diaz, L.; Kim, T. W.; Van Cutsem, E.; Geva, R.; Jäger, D.; Hara, H.; Burge, M.; O'Neil, B.; Kavan, P.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • CodeBreaK 101 subprotocol H: Phase Ib study evaluating combination of sotorasib (Soto), a KRASG12C inhibitor, and panitumumab (PMab), an EGFR inhibitor, in advanced KRAS p.G12C-mutated colorectal cancer (CRC)
    Meeting Abstract

    Fakih, M.; Falchook, G. S.; Hong, D. S.; Yaeger, R. D.; Chan, E.; Mather, O.; Cardona, P.; Dai, T.; Strickler, J.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Safety, efficacy, and pharmacodynamics of tremelimumab plus durvalumab for patients with unresectable hepatocellular carcinoma: Randomized expansion of a phase I/II study
    Journal Article

    Kelley, R. K.; Sangro, B.; Harris, W.; Ikeda, M.; Okusaka, T.; Kang, Y. K.; Qin, S.; Tai, D. W. M.; Lim, H. Y.; Yau, T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of germline testing in patients with advanced cancers
    Journal Article

    Stadler, Z. K.; Maio, A.; Chakravarty, D.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; Tkachuk, K.; Fong, C. J.; Nguyen, B.; Erakky, A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Pancreatic ductal adenocarcinoma in the era of precision medicine
    Review

    Zheng-Lin, B.; O'Reilly, E. M.
    Seminars in Oncology (2021)

    Fulltext@MSK | Save
  • Association of obesity with worse operative and oncologic outcomes for patients undergoing gastric cancer resection
    Journal Article

    Nakauchi, M.; Vos, E. L.; Tang, L. H.; Gonen, M.; Janjigian, Y. Y.; Ku, G. Y.; Ilson, D. H.; Maron, S. B.; Yoon, S. S.; Brennan, M. F.; more...
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save